Who is sponsoring NCT05584956?

NCT05584956 is sponsored by Tanta University.

What drugs are being tested in NCT05584956?

Interventions in NCT05584956: L_carnitine, Sildenafil.

Is NCT05584956 still recruiting?

NCT05584956 is currently status unknown. Last updated 18 October 2022.

Last reviewed 2022-10-18 · How we verify

NCT05584956

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study to Evaluate the Possible Efficacy and Safety of L- Carnitine and Sildenafil in Children Having Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity

Status unknown Phase 3 Last updated 18 October 2022

What this trial tests

Phase 3 trial testing L_carnitine in Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity in 44 participants. Status unknown.

Timeline

8 July 2022

Primary endpoint
8 July 2023

8 July 2024

Quick facts

Lead sponsor	Tanta University
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	44
Start date	8 July 2022
Primary completion	8 July 2023
Estimated completion	8 July 2024
Sites	1 location across Egypt

Drugs / interventions tested

L_carnitine
Sildenafil (sildenafil) — full drug profile →

Conditions studied

Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity — all drugs for Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity →

Sponsor

Tanta University

Who can join

Adults 6 to 18, any sex, with Beta Thalassemia With Increased Tricuspid Regurgitant Jet Velocity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the possible efficacy and safety of L\_Carnitine and Sildenafil on patient with Beta thalassemia complicated with increased Tricuspid Regurgitant Jet Velocity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05584956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 18 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05584956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing